(Total Views: 520)
Posted On: 10/23/2020 2:12:34 PM
Post# of 145875
Some are saying do not unblind and talking about their experience bringing products to market. I would think that their experience also told them that if the playing field changed then they needed to reassess their tactics. I see the FDA now proven willingness to approve big pharma drugs of doubtful benefit changes the playing field. I see AZar’s interview alluding to more such approvals as changing the playing field. I see Dr NPs previous statements that Britain and the Philippines among others wanted to see data as confirmation that a change in Cydy tactics would have merit. I have run large operations in life or death situations. You must be willing to adapt your tactics to changing opportunities and necessities. I have come to the conclusion that a change is merited and if the MHRA and Philippines discussions don’t bear immediate fruit then unblind the data!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)